Page 20 - Read Online
P. 20

Page 14 of 15          Magnifico et al. Rare Dis Orphan Drugs J 2023;2:16  https://dx.doi.org/10.20517/rdodj.2023.17

               Authors’ contributions
               Design of the methodology and the search algorithm: Magnifico G, Benvenuti S
               Blind selection of the articles: Magnifico G, Artuso I
               Writing of the manuscript: Magnifico G, Artuso I, Benvenuti S

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               This work was supported in part by Regione Lombardia, ITALY [FT5132], and by Fondazione Telethon
               [GSP21003].


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2023.

               REFERENCES
               1.       Loeber JG, Platis D, Zetterström RH, et al. Neonatal screening in europe revisited: An ISNS perspective on the current state and
                   developments since 2010. Int J Neonatal Screen 2021;7:15.  DOI  PubMed  PMC
               2.       Berg JS, Foreman AK, O'Daniel JM, et al. A semiquantitative metric for evaluating clinical actionability of incidental or secondary
                   findings from genome-scale sequencing. Genet Med 2016;18:467-75.  DOI  PubMed  PMC
               3.       Berg JS, Agrawal PB, Bailey DB Jr, et al. Newborn sequencing in genomic medicine and public health. Pediatrics 2017:139.  DOI
                   PubMed  PMC
               4.       Burlina A, Jones SA, Chakrapani A, et al. A new approach to objectively evaluate inherited metabolic diseases for inclusion on
                   newborn screening programmes. Int J Neonatal Screen 2022;8:25.  DOI  PubMed  PMC
               5.       Milko LV, O'Daniel JM, DeCristo DM, et al. An age-based framework for evaluating genome-scale sequencing results in newborn
                   screening. J Pediatr 2019;209:68-76.  DOI  PubMed  PMC
               6.       Ceyhan-Birsoy O, Machini K, Lebo MS, et al. A curated gene list for reporting results of newborn genomic sequencing. Genet Med
                   2017;19:809-18.  DOI  PubMed  PMC
               7.       Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria
                   over the past 40 years. Bull World Health Organ 2008;86:317-9.  DOI  PubMed  PMC
               8.       Pereira S, Robinson JO, Gutierrez AM, et al; BabySeq Project Group. Perceived benefits, risks, and utility of newborn genomic
                   sequencing in the babyseq project. Pediatrics 2019;143:S6-S13.  DOI  PubMed  PMC
               9.       Zacharias RL, Smith ME, King JS. The legal dimensions of genomic sequencing in newborn screening. Hastings Cent Rep 2018;48
                   Suppl 2:S39-41.  DOI  PubMed
               10.      Tarini BA, Goldenberg AJ. Ethical issues with newborn screening in the genomics era. Annu Rev Genomics Hum Genet 2012;13:381-
                   93.  DOI  PubMed  PMC
               11.      Lantos JD. Ethical and psychosocial issues in whole genome sequencing (WGS) for newborns. Pediatrics 2019;143:S1-5.  DOI
                   PubMed
               12.      Ross LF, Clayton EW. Ethical issues in newborn sequencing research: the case study of babyseq. Pediatrics 2019:144.  DOI  PubMed
                   PMC
               13.      Pichini A, Ahmed A, Patch C, et al. Developing a national newborn genomes program: an approach driven by ethics, engagement and
                   co-design. Front Genet 2022;13:866168.  DOI  PubMed  PMC
               14.      Holm IA, Agrawal PB, Ceyhan-Birsoy O, et al; BabySeq project team. the babyseq project: implementing genomic sequencing in
                   newborns. BMC Pediatr 2018;18:225.  DOI  PubMed  PMC
               15.      Schuijff M, Dijkstra AM. Practices of responsible research and innovation: a review. Sci Eng Ethics 2020;26:533-74.  DOI  PubMed
   15   16   17   18   19   20   21   22   23   24   25